The 5-Minute Guide to Horizon Pharma PLC Stock – The Motley Fool #valeant #pharma

Posted On Jan 7 2018 by

#horizon pharma # The 5-Minute Guide to Horizon Pharma PLC Stock Value investors don’t need to know a mitochondria from a hole in the ground to sense something’s amiss with Horizon Pharmaceuticals (NASDAQ:HZNP ) stock. Over the past several years the company’s sales have exploded, yet the stock fallen roughly 50% from its peak last summer. With a forward price-to-earnings ratio under 10, this looks like a bargain hunter’s dream come true. Before you go diving in, take five minutes to familiarize yourself with this company. You’ll be glad you did. Pharma-funds Even if you don’t follow pharmaceutical industry news, …


Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know – The Motley Fool #pharma #canada

Posted On Nov 25 2017 by

#raptor pharma # Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know Apr 7, 2016 at 1:15PM Shares of small-cap orphan drug developer Raptor Pharmaceutical (NASDAQ:RPTP ) surged 24% in Wednesday trading, after Reuters reported that investment bankers have been brought on board to discuss a sale of the company. Raptor has declined to comment on the rumors, however, and with Raptor stock now down 5% in Thursday morning trading, enthusiasm for the development may already be waning. But could it be that today’s 5% retracement is giving investors a chance to take a second bite at the apple …


Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know – The Motley Fool #new #pharmaceuticals

Posted On Nov 15 2017 by

#raptor pharma # Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know Apr 7, 2016 at 1:15PM Shares of small-cap orphan drug developer Raptor Pharmaceutical (NASDAQ:RPTP ) surged 24% in Wednesday trading, after Reuters reported that investment bankers have been brought on board to discuss a sale of the company. Raptor has declined to comment on the rumors, however, and with Raptor stock now down 5% in Thursday morning trading, enthusiasm for the development may already be waning. But could it be that today’s 5% retracement is giving investors a chance to take a second bite at the apple …


Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know – The Motley Fool #rusan #pharma

Posted On Nov 6 2017 by

#raptor pharma # Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know Apr 7, 2016 at 1:15PM Shares of small-cap orphan drug developer Raptor Pharmaceutical (NASDAQ:RPTP ) surged 24% in Wednesday trading, after Reuters reported that investment bankers have been brought on board to discuss a sale of the company. Raptor has declined to comment on the rumors, however, and with Raptor stock now down 5% in Thursday morning trading, enthusiasm for the development may already be waning. But could it be that today’s 5% retracement is giving investors a chance to take a second bite at the apple …


The 5-Minute Guide to Horizon Pharma PLC Stock – The Motley Fool #aton #pharma

Posted On Sep 30 2017 by

#horizon pharma # The 5-Minute Guide to Horizon Pharma PLC Stock Value investors don’t need to know a mitochondria from a hole in the ground to sense something’s amiss with Horizon Pharmaceuticals (NASDAQ:HZNP ) stock. Over the past several years the company’s sales have exploded, yet the stock fallen roughly 50% from its peak last summer. With a forward price-to-earnings ratio under 10, this looks like a bargain hunter’s dream come true. Before you go diving in, take five minutes to familiarize yourself with this company. You’ll be glad you did. Pharma-funds Even if you don’t follow pharmaceutical industry news, …


5 Incredibly Cheap Big Pharma Stocks – The Motley Fool #amylin #pharma

Posted On Sep 10 2017 by

#pharma stocks # 5 Incredibly Cheap Big Pharma Stocks Image source: Getty Images. This has been a roller-coaster year for pharmaceutical stocks. The iShares U.S. Pharmaceuticals index. which follows the performance of the largest U.S.-listed companies in the industry, is still 17% lower than where it stood 12 months ago. That’s well above low points seen earlier this year, but there are still some bargains out there. Research and acquisition-happy AbbVie (NYSE:ABBV ). Allergan (NYSE:AGN ). and Pfizer (NYSE:PFE ) are poised to grow faster than their prices imply. Generic giants Mylan (NASDAQ:MYL ) and Teva Pharmaceutical Industries (NYSE:TEVA ) …


5 Incredibly Cheap Big Pharma Stocks – The Motley Fool #pharmaceutical #suppliers

Posted On Aug 31 2017 by

#pharma stocks # 5 Incredibly Cheap Big Pharma Stocks Image source: Getty Images. This has been a roller-coaster year for pharmaceutical stocks. The iShares U.S. Pharmaceuticals index. which follows the performance of the largest U.S.-listed companies in the industry, is still 17% lower than where it stood 12 months ago. That’s well above low points seen earlier this year, but there are still some bargains out there. Research and acquisition-happy AbbVie (NYSE:ABBV ). Allergan (NYSE:AGN ). and Pfizer (NYSE:PFE ) are poised to grow faster than their prices imply. Generic giants Mylan (NASDAQ:MYL ) and Teva Pharmaceutical Industries (NYSE:TEVA ) …


Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know – The Motley Fool #astellas #pharma #inc

Posted On Aug 17 2017 by

#raptor pharma # Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know Apr 7, 2016 at 1:15PM Shares of small-cap orphan drug developer Raptor Pharmaceutical (NASDAQ:RPTP ) surged 24% in Wednesday trading, after Reuters reported that investment bankers have been brought on board to discuss a sale of the company. Raptor has declined to comment on the rumors, however, and with Raptor stock now down 5% in Thursday morning trading, enthusiasm for the development may already be waning. But could it be that today’s 5% retracement is giving investors a chance to take a second bite at the apple …


The 5-Minute Guide to Horizon Pharma PLC Stock – The Motley Fool #ajanta #pharma #products

Posted On Aug 7 2017 by

#horizon pharma # The 5-Minute Guide to Horizon Pharma PLC Stock Value investors don’t need to know a mitochondria from a hole in the ground to sense something’s amiss with Horizon Pharmaceuticals (NASDAQ:HZNP ) stock. Over the past several years the company’s sales have exploded, yet the stock fallen roughly 50% from its peak last summer. With a forward price-to-earnings ratio under 10, this looks like a bargain hunter’s dream come true. Before you go diving in, take five minutes to familiarize yourself with this company. You’ll be glad you did. Pharma-funds Even if you don’t follow pharmaceutical industry news, …


Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know – The Motley Fool #generic #pharma #companies

Posted On Jul 25 2017 by

#raptor pharma # Raptor Pharmaceutical Stock Upgraded: 3 Things You Need to Know Apr 7, 2016 at 1:15PM Shares of small-cap orphan drug developer Raptor Pharmaceutical (NASDAQ:RPTP ) surged 24% in Wednesday trading, after Reuters reported that investment bankers have been brought on board to discuss a sale of the company. Raptor has declined to comment on the rumors, however, and with Raptor stock now down 5% in Thursday morning trading, enthusiasm for the development may already be waning. But could it be that today’s 5% retracement is giving investors a chance to take a second bite at the apple …